Consistently with the above evidence, in the clinical setting, it has been widely observed that patients with CRA as well as anemia of chronic inflammatory disease have elevated hepcidin values (Basseri et al., 2012; Shu et al., 2014). This evidence concerns the gene HAMP and anemia.